Kathleen T. Brady, M.D., Ph.D., Medical University of South Carolina (MUSC), will use her NIDA Distinguished International Scientist Collaboration Award (USDISCA) to extend her research collaboration with Maree Teesson, Ph.D., Australian National Drug and Alcohol Research Centre (NDARC), University of New South Wales. The team will collaborate on statistical analysis, interpretation, and dissemination of research findings on treatment of co-occurring post-traumatic stress disorder (PTSD) and substance use disorders in preparation for publications and a 2011 international symposium on the topic. Drs. Brady and Teesson also will explore capacity development in multisite clinical trials, translational research, and concept development. Dr. Brady directs the Clinical Neuroscience Division at MUSC, focusing on substance use disorders and co-occurring psychiatric and medical conditions, is the principal investigator of the NIDA Clinical Trials Network Southern Consortium Node, and is MUSC Associate Dean for Clinical and Translational Research.
Archives